Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BCR anticorps

L’anticorps Lapin Polyclonal anti-BCR a été validé pour WB et EIA. Il convient pour détecter BCR dans des échantillons de Humain et Souris.
N° du produit ABIN265328

Aperçu rapide pour BCR anticorps (ABIN265328)

Antigène

Voir toutes BCR Anticorps
BCR (Breakpoint Cluster Region (BCR))

Reactivité

  • 95
  • 52
  • 26
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Souris

Hôte

  • 89
  • 4
  • 4
Lapin

Clonalité

  • 92
  • 5
Polyclonal

Conjugué

  • 57
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BCR est non-conjugé

Application

  • 68
  • 38
  • 32
  • 26
  • 26
  • 25
  • 18
  • 13
  • 12
  • 9
  • 6
  • 4
  • 3
  • 2
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Specificité

    The antibody detects endogenous levels of BCR protein (region surrounding Asp171).

    Réactivité croisée (Details)

    Species reactivity (expected):Mouse and Rat.
    Species reactivity (tested):Human.

    Purification

    The antibody was affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen

    Pureté

    > 95 % pure by SDS-PAGE
  • Indications d'application

    ELISA: 1: 10000approx. 1: 20000. WB: 1: 500approx. 1: 1000.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Phosphate buffered saline (PBS), pH 7.2., 0.05 % Sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène

    BCR (Breakpoint Cluster Region (BCR))

    Autre désignation

    BCR

    Sujet

    The Bcr gene, mapping on chromosome 22, was initially identified on the basis of its fusion with the c-Abl proto-oncogene on chromosome 9 resulting in the generation of the Philadelphia chromosome in 90-95 % of patients with chronic myelogenous leukemia (CML). The Bcr gene encodes for the Breakpoint cluster region protein (Bcr). A consequence of this translocation is the generation of a Bcr/c-Abl mRNA encoding an activated c-Abl protein kinase. The Bcr gene has been shown to encode a 160 kDa GTPase-activating protein (GAP) specific for the Ras-related GTP-binding protein, Rac 1 p21. While it has been speculated that the Bcr protein may also stimulate Rac 2 p21 GTPase activity, it has no effect on Ras p21 or Rho p21 GTPases. It is of interest that the GAP domain of Bcr maps outside of the region that remains on chromosome 22 (Philadelphia chromosome) in CML.Synonyms: BCR1, Breakpoint cluster region protein, D22S11, NY-REN-26, Renal carcinoma antigen NY-REN-26

    Poids moléculaire

    approx. 160 kDa

    ID gène

    613

    NCBI Accession

    NP_004318

    UniProt

    P11274

    Pathways

    Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
Vous êtes ici:
Chat with us!